These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23913179)

  • 1. Establishment and preliminary application of a rapid fluorescent focus inhibition test (RFFIT) for rabies virus.
    Yu P; Lv X; Shen X; Tang Q; Liang G
    Virol Sin; 2013 Aug; 28(4):223-7. PubMed ID: 23913179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.
    Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C
    Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study.
    Li R; Li Y; Wen S; Wen H; Nong Y; Mo Z; Xie F; Pellegrini M
    Hum Vaccin Immunother; 2015; 11(2):435-42. PubMed ID: 25692350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen).
    Mahendra BJ; Narayana DA; Agarkhedkar S; Ravish HS; Harish BR; Agarkhedkar S; Madhusudana SN; Belludi A; Ahmed K; Jonnalagedda R; Vakil H; Bhusal C; Arora AK
    Hum Vaccin Immunother; 2015; 11(2):428-34. PubMed ID: 25692792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
    Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above.
    Wang J; Luo F; Feng Z; Li L; Bai Y; Ai X; Ma J; Zhang Z; Shi N
    Hum Vaccin Immunother; 2017 Jan; 13(1):144-150. PubMed ID: 28045585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The establishment of a rapid fluorescent focus inhibition test for testing rabies virus neutralizing antibody].
    Yu PC; Lv XJ; Shen XX; Cao L; Zheng XX; Shan H; Tang Q
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Apr; 31(4):438-41. PubMed ID: 20513292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protecting Indian schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV).
    Shanbag P; Shah N; Kulkarni M; Juvekar M; Madhusudana SN; Vakil HB; Malerczyk C
    Hum Vaccin; 2008; 4(5):365-9. PubMed ID: 18398307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Corticosteroids on RVNA production of a patient with acute disseminated encephalomyelitis following rabies vaccination as well as administration of HRIG.
    Peng J; Chen L; Zhu ZG; Zhu ZR; Hu Q; Fang Y
    Hum Vaccin Immunother; 2014; 10(12):3622-6. PubMed ID: 25668669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India.
    Sudarshan MK; Narayana DH; Madhusudana SN; Holla R; Ashwin BY; Gangaboraiah B; Ravish HS
    Hum Vaccin Immunother; 2012 Aug; 8(8):1077-81. PubMed ID: 22699446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new recombinant rabies virus expressing a green fluorescent protein: A novel and fast approach to quantify virus neutralizing antibodies.
    Qin S; Volokhov D; Rodionova E; Wirblich C; Schnell MJ; Chizhikov V; Dabrazhynetskaya A
    Biologicals; 2019 May; 59():56-61. PubMed ID: 30898479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of two commercially available ELISAs and one in-house reference laboratory ELISA for the determination of human anti-rabies virus antibodies.
    Welch RJ; Anderson BL; Litwin CM
    J Med Microbiol; 2009 Jun; 58(Pt 6):806-810. PubMed ID: 19429758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid fluorescent focus inhibition test optimization and validation: Improved detection of neutralizing antibodies to rabies virus.
    Timiryasova TM; Luo P; Zheng L; Singer A; Zedar R; Garg S; Petit C; Moore S; Hu BT; Brown M
    J Immunol Methods; 2019 Nov; 474():112626. PubMed ID: 31228423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of saftey and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ML.
    Madhusudana SN; Sanjay TV; Mahendra BJ; Sudarshan MK; Narayana DH; Giri A; Muhamuda K; Ravi V; Vakil HB; Malerczyk C
    Hum Vaccin; 2006; 2(5):200-4. PubMed ID: 17035734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT.
    Um J; Chun BC; Lee YS; Hwang KJ; Yang DK; Park JS; Kim SY
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006084. PubMed ID: 29267277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of safety and immunogenicity of PVRV and PCECV immunized in patients with WHO category II animal exposure: a study based on different age groups.
    Fang Y; Chen L; Liu MQ; Zhu ZG; Zhu ZR; Hu Q
    PLoS Negl Trop Dis; 2014 Dec; 8(12):e3412. PubMed ID: 25522244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays.
    Moore SM; Ricke TA; Davis RD; Briggs DJ
    Biologicals; 2005 Dec; 33(4):269-76. PubMed ID: 16168666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China.
    Hu Q; Liu MQ; Zhu ZG; Zhu ZR; Lu S
    Hum Vaccin Immunother; 2014; 10(6):1645-9. PubMed ID: 24632727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab).
    Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M
    Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of a new immunohistochemistry-based test for the detection of rabies virus neutralizing antibodies.
    Madhusudana SN; Malavalli BV; Thankappan UP; Sundramoorthy S; Belludi AY; Pulagumbaly SB; Sanyal S
    Hum Vaccin Immunother; 2014; 10(5):1359-65. PubMed ID: 24583787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.